Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Deoxycorticosterone acetate
Cat. No.:
0225LY-1212
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Deoxycorticosterone acetate is a 21-acetate derivative of desoxycorticosterone used as an injectable replacement therapy for adrenocortical steroids.
Synonym:
DOC acetate; Cortexone acetate; 11-Deoxycorticosterone acetate; 56-47-3; DOCA; Desoxycortone acetate; Percotol; Cortexone acetate; Decosteron; Decosterone; Sincortex; DOC acetate; 11-Deoxycorticosterone acetate; Decostrate; Descorterone; Docaquosum; Dorcostrin; Krinocorts; Primocortan; Cortacet; Cortate; Cortenil; Cortesan; Cortifar; Cortinaq; Cortiron; Cortivis; Cortixyl; Decorten; Descornaq; Doxatone; Doxycamon; Mincortid; Ocriten; Ocritena; Primocort; Syncorta; Syncortyl; Unidocan; Arcort; Pregn-4-ene-3,20-dione, 21-(acetyloxy)-; Steraq; Deoxycortone acetate; Bio-Corten; Doc-Ac; Desoxykorton; Cortigen; Cortormon; Percortene; Doca acetate; DOXO; Organon's doca acetate; 3,20-Dioxopregn-4-en-21-yl acetate; 21-Acetoxypregn-4-ene-3,20-dione; Deoxycorticosterone 21-acetate; 11-Desoxycorticosterone acetate; Desoxycorticosterone-21-acetate; Corticosterone, deoxy-, acetate; 4-Pregnene-3,20-dione-21-ol acetate; 11-Deoxycorticosterone 21-acetate; Decorton; Desocort; Syncort; 4-Pregnene-3,20-dione 21-acetate; 21-Acetoxy-3,20-diketopregn-4-ene
CAS No.:
56-47-3
Compound CID:
5952
Formula:
C23H32O4
Formula Weight:
372.5
Specification
Relative Density:
1.0415 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Deoxycorticosterone acetate can be used in endocrinology to study the biological effects of mineralocorticoids on electrolyte balance and blood pressure.
Library Information
Target:
Adrenergic receptor; Glucocorticoid receptor
Receptor:
Adrenergic receptor; Mineralocorticoid receptor
Pathways:
Neuronal signaling; Metabolism; GPCR/G protein signaling; Endocrinology/Hormones
Plate Number:
AOCL-16
Plate Location:
e9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
13.47 mg/mL; 36.16 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
12.5 mg/mL; 33.56 mM
ALogP:
3.567
HBA_Count:
4
HBD_Count:
0
Rotatable Bond:
4





